Skip to content
Recall Observatory FDA recall evidence

Drug product

Moxifloxacin PF, 1mg/ml, in Sterile Balanced Salt Solution (BSS) Sterile injection, Intracameral Use Only, Single- Dose Vial, Leiters 13796 Compark Blvd, Englewood, CO 80112, NDC 71449-096-42

D-0361-2024

February 20, 2024

Class II

Product summary

Firm
Denver Solutions, LLC DBA Leiters Health
Event
Event 94071
Status
Ongoing
Classification
Class II
Quantity
40,090 vials
Official record key
drug-enforcement:D-0361-2024

Official wording

Reason: Presence of Particulate Matter: glass vials from the manufacturer showed signs of glass delamination.

Code information: Lot #:2331147, Exp:6-Mar-24; 2331180, Exp: 21-Mar-24; 2331256, Exp: 2-Apr-24; 2331279, Exp: 3-Apr-24; 2331283, Exp: 7-Apr-24; 2331345, Exp: 20-Apr-24; 2331422, Exp: 27-Apr-24; 2331563, Exp: 29-May-24.

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    Particulate Matter